Related Experiment Video
Updated: Aug 8, 2026
12:05
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
Flow cytometry in the diagnosis in hematologic diseases
Annals of Clinical and Laboratory Science
|November 1, 1986
Summary
Flow cytometry advances enable clinical labs to phenotype leukocytes for diagnosing cancers and immune disorders. This technology aids in managing diseases like leukemia, lymphoma, and AIDS by analyzing cell components.
Area of Science:
- Clinical Immunology
- Cell Biology
- Medical Technology
Background:
- Recent advancements in instrumentation and reagents have spurred interest in clinical flow cytometry.
- Flow cytometry enables measurement of various cell constituents and functions.
Observation:
- Commercially available flow cytometers and monoclonal antibodies facilitate clinical laboratory applications.
- Applications include phenotyping leukocytes in leukemias, lymphomas, immunological disorders, transplant patients, and infectious diseases.
Findings:
- Flow cytometry allows measurement of deoxyribonucleic acid (DNA), ribonucleic acid (RNA), proteins, enzymes, and hormone receptors.
- Simultaneous phenotyping with monoclonal antibodies enhances the value of these measurements.
- Studies on patients with lymphomas, leukemias, AIDS-related complex, and other immune disorders confirm its diagnostic and management utility.
Implications:
- Flow cytometry is a valuable tool for the diagnosis and management of various hematologic and immunologic conditions.
- Its integration into clinical practice supports personalized medicine approaches.
- Further development promises expanded applications in disease monitoring and therapeutic guidance.
